Efficacy Definitions for Migraine Studies-Reference-Cited by-同舟云学术

Efficacy Definitions for Migraine Studies

Published:1999-05 Issue:4 Volume:19 Page:248-249
ISSN:0333-1024
Container-title:Cephalalgia
language:en
Short-container-title:Cephalalgia

Author:

Goldstein DJ¹,Offen WW¹,Moster MB¹

Affiliation:

1. Neuroscience Therapeutic Area, Lilly Research Laboratories, Indianapolis, IN, USA; Department of Toxicology and Pharmacology, Indiana University Medical School, Indianapolis, IN, USA; Department of Pediatrics, Methodist Hospital of Indiana, Indianapolis, IN, USA.

Publisher

SAGE Publications

Subject

Clinical Neurology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.1999.019004248.x

Reference7 articles.

1. Guidelines for Controlled Trials of Drugs in Migraine. First Edition

2. Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine

3. Double-Blind, Placebo-Controlled, Dose-Finding Study of Rizatriptan (MK-462) in the Acute Treatment of Migraine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Potential Receptors of Migraine with a Special Emphasis on CGRP to Develop an Ideal Antimigraine Drug;Current Molecular Pharmacology;2020-12-31

2. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition;Cephalalgia;2019-04-04

3. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition;Cephalalgia;2019-02-26

4. What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint;Cephalalgia;2014-08-18

5. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators;Cephalalgia;2012-01